SEC Form 4 Reporting Owner · CIK 0001164426
Joseph Edelman
Director at LeonaBio Inc · Director at Immatics N V · 10%+ at Freenome Inc · +31 more
Bought (12 mo)
+$7.5M
Sold (12 mo)
−$527K
Form 4 Filings
137
Companies
34
Filing Activity
2026-10-26
first filed 2021-01-11
Trading record
Open-market buys
+$606M
72 filings
Open-market sales
−$62.1M
23 filings
Sales under a 10b5-1 plan
0%
0 of 23 sale filings · 16 undisclosed
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| LONALeonaBio Insider trading | Director | 14 | 2,288,159 | — | +2,288,159 | 2,635,970 2026-10-26 |
| IMTXImmunocore Insider trading | Director | 1 | 863,060 | — | +863,060 | 11,246,516 2026-08-27 |
| FRNMPerceptive Capital Insider trading | 10%+ | 1 | — | — | — | 10,871,847 2026-07-23 |
| KARDKardigan Insider trading | Director | 1 | — | — | — | 20,706 2026-07-13 |
| MGTXMeiraGTx Insider trading | Director | 10 | 5,597,826 | — | +5,597,826 | 10,786,658 2026-04-24 |
| SLDBSolid Biosciences Insider trading | Director | 11 | 11,019,408 | — | +11,019,408 | 11,906,646 2025-02-21 |
| LYRALyra Therapeutics Insider trading | 10%+ | 4 | 9,535,002 | 116,265 | +9,418,737 | 14,026 2025-11-13 |
| ADGMAdagio Medical Insider trading | 10%+ | 2 | — | — | — | 9,876,586 2025-02-14 |
| OBIOOrchestra BioMed Insider trading | 10%+ | 1 | 700,000 | — | +700,000 | 5,292,556 2025-08-05 |
| ACRVAcrivon Insider trading | 10%+ | 3 | 2,353,000 | 2,256,719 | +96,281 | 3,104,139 2025-05-01 |
| ALDXAldeyra Therapeutics Inc Insider trading | 10%+ | 16 | 5,746,892 | 6,156,499 | −409,607 | 5,875,851 2025-04-07 |
| ARYDArya Sciences Insider trading | Director | 1 | — | — | — | — |
| NAUTNautilus Biotechnology Insider trading | Director | 7 | 6,197,038 | — | +6,197,038 | 9,111,151 2021-12-10 |
| CERECerevel Therapeutics Insider trading | Director | 5 | 1,320,440 | — | +1,320,440 | 10,794,876 2024-02-21 |
| LIANLianBio Insider trading | Director | 8 | 3,728,491 | — | +3,728,491 | 57,594,751 2024-02-20 |
| ATXSAstria Therapeutics Insider trading | Director | 5 | 5,204,223 | — | +5,204,223 | 6,485,420 2024-02-05 |
| VRCAVerrica Pharmaceuticals Insider trading | 10%+ | 4 | 3,488,770 | — | +3,488,770 | 7,099,182 2023-12-29 |
| CRGXCARGO Therapeutics Insider trading | Other | 1 | 666,666 | — | +666,666 | 2,912,835 2023-11-14 |
| SLNOSOLY Insider trading | 10%+ | 5 | 1,210,087 | — | +1,210,087 | 3,074,542 2023-09-28 |
| CEMIChembio Diagnostics Insider trading | Other | 6 | 1,490,120 | — | +1,490,120 | 0 2023-05-01 |
| VBIVVBI Vaccines Insider trading | 10%+ | 4 | — | 15,671,036 | −15,671,036 | 41,440,729 2023-04-06 |
| LABPLandos Biopharma Insider trading | 10%+ | 4 | 1,500,187 | — | +1,500,187 | 17,960,839 2021-02-09 |
| QTNTQuotient Insider trading | 10%+ | 1 | — | 8,255,607 | −8,255,607 | 7,945,211 2022-11-02 |
| ALBOAlbireo Pharma Inc Insider trading | 10%+ | 1 | — | 420,416 | −420,416 | 1,939,723 2022-10-13 |
| CRNXCrinetics Pharmaceuticals Insider trading | 10%+ | 3 | 1,661,651 | — | +1,661,651 | 5,321,032 2022-04-18 |
| AGRXAgile Therapeutics Insider trading | 10%+ | 2 | 5,734,560 | — | +5,734,560 | 21,654,485 2021-10-15 |
| ISOIsoPlexis Insider trading | 10%+ | 1 | 850,000 | — | +850,000 | 3,554,587 2021-10-14 |
| RAINRain Oncology Insider trading | 10%+ | 2 | 550,000 | 50,000 | +500,000 | 2,487,019 2021-10-13 |
| ADMAADMA Biologics Insider trading | 10%+ | 4 | — | 3,322,427 | −3,322,427 | 13,262,375 2021-09-30 |
| LPTXCypherpunk Insider trading | 10%+ | 1 | — | — | — | — |
| VYNEYarrow Bioscience Insider trading | 10%+ | 5 | 4,219,409 | 1,838,897 | +2,380,512 | 4,935,057 2021-08-18 |
| RXDXPrometheus Insider trading | 10%+ | 1 | 850,000 | — | +850,000 | 3,314,032 2021-03-16 |
| SCYXSCYNEXIS Insider trading | 10%+ | 1 | — | 599,000 | −599,000 | 1,800,000 2021-01-26 |
| MOTSMotus GI Insider trading | 10%+ | 1 | — | 1,550,000 | −1,550,000 | 2,660,542 2021-01-22 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.